Announcements and Notices - [Other - Business Update]

Sinomab Bioscience Limited manufactures antibody drugs. The Company researches, develops, and manufactures anti-infective drugs, antitumor agents, and monoclonal antibodies. Sinomab Bioscience markets its products worldwide.

Voluntary Announcement
First Cohort Of Healthy Subjects
Dosed With Subcutaneous Formulation Of Sm17
In A Bridging Study In China

Announcements and Notices - [Change in Company Secretary]

Change Of Company Secretary

Notification Letter To Non-Registered Shareholders And Reply Form

Notification Letter To Registered Shareholders And Reply Form

Financial Statements/ESG Information - [Interim/Half-Year Report]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Sinomab Bioscience Ltd (3681 HK)

Voluntary Announcement First Cohort Of Healthy Subjects Dosed With Subcutaneous Formulation Of Sm17 In A Bridging Study In China

Change Of Company Secretary

Notification Letter To Non-Registered Shareholders And Reply Form

Notification Letter To Registered Shareholders And Reply Form

Interim Report 2025

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)